Numerous studies have demonstrated that SCFAs regulate metabolic disorders and immunity mainly through the inhibition of histone deacetylases and the activation of G protein-coupled receptors such as GPR41, GPR43 and GPR109a [55]. Here, FFAR3 is linked to metabolic disease.